Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Imbruvica

Descriptions


Ibrutinib is used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) in patients with 17p deletion, and Waldenström macroglobulinemia (WM). It is also used to treat chronic graft-versus-host disease (cGHVD) after one or more lines of treatment did not work. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Ibrutinib is an antineoplastic agent (cancer medicine).

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Capsule
  • Tablet
  • Suspension

Portions of this document last updated: May 01, 2024

Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.